Dyskinesia
Author | : D.E. Casey |
Publisher | : Springer Science & Business Media |
Total Pages | : 368 |
Release | : 2013-03-12 |
Genre | : Medical |
ISBN | : 364270140X |
Papers Presented at an International Symposium, Held in 1984 at Kollekolle, Denmark
Download Management Of Tardive Dyskinesia full books in PDF, epub, and Kindle. Read online free Management Of Tardive Dyskinesia ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author | : D.E. Casey |
Publisher | : Springer Science & Business Media |
Total Pages | : 368 |
Release | : 2013-03-12 |
Genre | : Medical |
ISBN | : 364270140X |
Papers Presented at an International Symposium, Held in 1984 at Kollekolle, Denmark
Author | : Stewart Factor |
Publisher | : John Wiley & Sons |
Total Pages | : 480 |
Release | : 2008-04-15 |
Genre | : Medical |
ISBN | : 140513755X |
The second revised edition of this text will update and present current state of the art clinical approaches to this subject. This book will continue to be the source text of information on drug-induced movement disorders authored and edited by the pioneers in the field. It will be an invaluable addition to the library of any neurologist.
Author | : D. G. Cunningham Owens |
Publisher | : Cambridge University Press |
Total Pages | : 370 |
Release | : 1999-03-11 |
Genre | : Medical |
ISBN | : 9780521633536 |
A very readable and well illustrated 1999 clinical guide to the common side effects of antipsychotic medication.
Author | : American Psychiatric Association. Task Force on Tardive Dyskinesia |
Publisher | : American Psychiatric Pub |
Total Pages | : 300 |
Release | : 1992 |
Genre | : Medical |
ISBN | : 9780890422304 |
Since the APA's last report on tardive dyskinesia in 1979, considerable research has been conducted on the prevalence, incidence, and risk factors associated with the development of late-occurring neuroleptic side effects. This book summarizes the progress made over the last decade in understanding the differential diagnosis and epidemiology of tardive dyskinesia, as well as risk factors, course, and treatment. The reader will benefit from the book's coverage of * indications for neuroleptic use* alternative maintenance strategies* factors to consider in making a differential diagnosis* frequently encountered problems in dealing with special populations such as children and mentally retarded people* clinical-legal issues related to tardive dyskinesia * clearly specified recommendations for prevention and management
Author | : Joseph F. Goldberg, M.D., M.S. |
Publisher | : American Psychiatric Pub |
Total Pages | : 618 |
Release | : 2018-08-10 |
Genre | : Medical |
ISBN | : 1585624888 |
"This book has been divided into three main sections. Part I deals with global issues that bear on the assessment and formulation of possible adverse effects and with pertinent concepts related to basic pharmacology, physiology, and medical monitoring. The chapters in Part II present information organized by individual organ systems or specific medical circumstances rather than by drugs or drug classes. This approach seems to provide a logical and comprehensible format that allow readers to search out information as referenced by a particular side effect (and its varied potential causes) and to locate a discussion of practical management strategies. Part III focuses on summary recommendations covering all the material presented in the book and is followed by helpful appendixes on self-assessment questions and resources for practitioners. The book is meant to serve as a ready reference that simultaneously provides scientific and scholarly discussion of available treatment options and presents their scientific rationales."--page xx.
Author | : Charles D. Ciccone |
Publisher | : F.A. Davis |
Total Pages | : 1217 |
Release | : 2013-03-21 |
Genre | : Medical |
ISBN | : 0803640048 |
A one-of-a-kind guide specifically for rehabilitation specialists! A leader in pharmacology and rehabilitation, Charles Ciccone, PT, PhD offers a concise, easy-to-access resource that delivers the drug information rehabilitation specialists need to know. Organized alphabetically by generic name, over 800 drug monographs offer the most up-to-date information on drug indications, therapeutic effects, potential adverse reactions, and much more! A list of implications for physical therapy at the end of each monograph helps you provide the best possible care for your patients. It’s the perfect companion to Pharmacology in Rehabilitation, 4th Edition!
Author | : World Health Organization |
Publisher | : World Health Organization |
Total Pages | : 80 |
Release | : 2009 |
Genre | : Medical |
ISBN | : 9241547693 |
This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.
Author | : Peter Haddad |
Publisher | : Oxford University Press |
Total Pages | : 334 |
Release | : 2004-05-27 |
Genre | : Medical |
ISBN | : 0198527489 |
Pharmacotherapy is an important part of the treatment of major phychiatric disorders. Although psychiatric drugs can have benefits for patients, adverse syndromes are common, causing distress for patients. This book will help psychiatrists, GPs pharmacists and nurses manage adverse syndromes associated with psychiatric drugs.
Author | : Dirk Dressler |
Publisher | : Cambridge University Press |
Total Pages | : 481 |
Release | : 2018-06-07 |
Genre | : Medical |
ISBN | : 1316997936 |
Our understanding of dystonia is advancing rapidly. This comprehensive reference work provides an effective guide to this challenging group of disorders, offering an overview of the current and emerging treatment options for all manifestations. Treatments for the many forms of dystonia differ substantially in pediatrics and adults - both are covered in detail in this book. Approaches include botulinum toxin therapy, deep brain stimulation, oral drug applications, rehabilitation, and behavioral and experimental therapies. Special emphasis is also given to combining different treatment modalities in order to achieve optimal effect. Treatment of Dystonia brings together peer-reviewed articles, written by experts and based on work presented at international conferences. By enabling the physician to select and combine the best therapies, it is an essential resource for neurologists, neurosurgeons and physical therapists.
Author | : Joseph H. Friedman |
Publisher | : Cambridge University Press |
Total Pages | : 210 |
Release | : 2020-05-07 |
Genre | : Medical |
ISBN | : 9781316636817 |
Medications that may produce movement disorders are widely used. The resulting disorders are often highly disconcerting for the patient and their relatives, especially when the connection between medication and disorder is not recognized. However, ascribing an adverse drug effect to medication exposure is often difficult, especially when the side effect is rare. Covering various drugs - including the major classes of medications working primarily on the brain, specifically antipsychotics and antidepressants - this all-encompassing review of medication-induced movement disorders aids early recognition and improved treatment. The problem of what to do when the offending medication cannot be reduced is also reviewed. It discusses the best options for evaluation and treatment, including medical imaging and deep brain stimulation, and guides the clinician in managing the disorder, making this a vital reference for medical specialists and consultants in neurology and neuropharmacology and any clinician seeing patients on medications crossing the blood brain barrier.